| 2019-11 | Negative Regulation of Osteoclast Commitment by Intracellular Protein Phosphatase Magnesium- Dependent 1A | 김태환 |
| 2011-06 | network analysis을 이용한 류마티스관절염 활액 대식세포에서 유전자 발현 연구 | 김태환 |
| 2013-06 | NEW CONCEPT OF SQUARING SCORE TO EVALUATE 1ST SACRUM IN MODIFIED STOKE ANKYLOSING SPONDYLITIS SPINAL SCORE | 김태환 |
| 2017-09 | A novel role for bone-derived cells in ankylosing spondylitis: Focus on IL-23 | 김태환 |
| 2012-12 | NSAIDs and radiographic progression in ankylosing spondylitis | 김태환 |
| 2013-06 | PILOT TRIAL OF TOCILIZUMAB FOR REFRACTORY PATIENTS WITH ADULT ONSET STILL'S DISEASE | 김태환 |
| 2018-11 | Poly-gamma-glutamic acid suppresses osteoclastogenesis in human osteoclast precursors and prevents joint damage in a collagen-induced murine arthritis model | 김태환 |
| 2011-09 | Polymorphisms of tumor necrosis factor-alpha promoter region for susceptibility to HLA-B27-positive ankylosing spondylitis in Korean population | 김태환 |
| 2020-05 | Predictive Value of Semi-quantitative Index from F-18-fluoride PET/CT for Treatment Response in Patients with Ankylosing Spondylitis | 김태환 |
| 2019-03 | Prefoldin 5 and anti-prefoldin 5 antibodies as biomarkers for uveitisi in ankylosing spondylitis | 김태환 |
| 2014-08 | The presence of peripheral arthritis delays spinal radiographic progression in ankylosing spondylitis: Observation Study of the Korean Spondyloarthropathy Registry | 김태환 |
| 2016-09 | Prevalence and possible causes of hypouricemia at a tertiary care hospital | 김태환 |
| 2014-06 | PREVALENCE AND POSSIBLE CAUSES OF HYPOURICEMIA AT A TERTIARY CARE HOSPITAL IN SOUTH KOREA | 김태환 |
| 2012-12 | Prevalence and Risk Factors of Anterior Atlantoaxial Subluxation in Ankylosing Spondylitis | 김태환 |
| 2016-06 | Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study | 김태환 |
| 2020-06 | Proteomic analysis of human synovial fluid reveals potential diagnostic biomarkers for ankylosing spondylitis | 김태환 |
| 2016-10 | Radiographic progression in patients with ankylosing spondylitis according to tumor necrosis factor blocker exposure: Observation Study of Korean Spondyloarthropathy Registry (OSKAR) data | 김태환 |
| 2020-03 | Radiographic progression in patients with ankylosing spondylitis according to uveitis based on the observation study of korean spondyloarthropathy registry | 김태환 |
| 2016-02 | Radiologic Changes in the Symphysis Pubis of Male Patients with Ankylosing Spondylitis | 김태환 |
| 2019-02 | Radiologic features in symptomatic/asymptomatic heels of patients with ankylosing spondylitis | 김태환 |
| 2019-02 | Regulation of osteoblasts by alkaline phosphatase in ankylosing spondylitis | 김태환 |
| 2014-03 | The Reliability and Validity of a Korean Translation of the ASAS Health Index and Environmental Factors in Korean Patients with Axial Spondyloarthritis | 김태환 |
| 2020-10 | Response to 'Correspondence on "Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence" by Zhanget al | 김태환 |
| 2018-09 | Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study | 김태환 |
| 2021-02 | RNA interference-mediated suppression of TNF-α converting enzyme as an alternative anti-TNF-α therapy for rheumatoid arthritis | 김태환 |
| 2021-01 | The role of ixekizumab in non-radiographic axial spondyloarthritis | 김태환 |
| 2016-04 | Safety of Resuming Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis Patients Concomitant with the Treatment of Active Tuberculosis: A Retrospective Nationwide Registry of the Korean Society of Spondyloarthritis Research | 김태환 |
| 2020-11 | Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5 | 김태환 |
| 2014-09 | SKI306X inhibition of glycosaminoglycan degradation in human cartilage involves down-regulation of cytokine-induced catabolic genes | 김태환 |
| 2012-02 | Soluble triggering receptor expressed on myeloid cells-1 as a new therapeutic molecule in rheumatoid arthritis | 김태환 |
